Table: Modalis Therapeutics -Q1 group results

Modalis Therapeutics

09/05/2023 07:00

May 9 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2023        Mar 31, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales                                40 mln                     
                (-100.0 pct)                                      
  Operating     loss 514 mln        loss 466 mln                  
  Recurring     loss 509 mln        loss 443 mln                  
  Net           loss 532 mln        loss 438 mln                  
  EPS          loss 17.86 yen      loss 15.13 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T